At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 13 enrolled
Drug / intervention
PF-04958242 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects
In Brief
A Phase 1 clinical trial evaluating PF-04958242 and Itraconazole for Healthy. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The purpose of the current study is to characterize the pharmacokinetic (PK) profile of PF 04958242 when co administered with a strong cytochrome P450 3A4 (CYP3A4) inhibitor.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 2015
Enrollment StartFeb 2015
Primary CompletionMar 2015
TodayJul 2026
First PostedJan 19, 2015
Enrollment StartFeb 5, 2015
Primary CompletionMar 31, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.5 years ago
Interventions
PF-04958242drug
Administered as specified in the treatment arm
Itraconazoledrug
Administered as specified in the treatment arm